Konstantin Zhernosekov

2.2k total citations · 1 hit paper
33 papers, 1.7k citations indexed

About

Konstantin Zhernosekov is a scholar working on Radiology, Nuclear Medicine and Imaging, Pulmonary and Respiratory Medicine and Epidemiology. According to data from OpenAlex, Konstantin Zhernosekov has authored 33 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 25 papers in Radiology, Nuclear Medicine and Imaging, 12 papers in Pulmonary and Respiratory Medicine and 10 papers in Epidemiology. Recurrent topics in Konstantin Zhernosekov's work include Radiopharmaceutical Chemistry and Applications (25 papers), Medical Imaging Techniques and Applications (14 papers) and Neuroendocrine Tumor Research Advances (10 papers). Konstantin Zhernosekov is often cited by papers focused on Radiopharmaceutical Chemistry and Applications (25 papers), Medical Imaging Techniques and Applications (14 papers) and Neuroendocrine Tumor Research Advances (10 papers). Konstantin Zhernosekov collaborates with scholars based in Germany, Switzerland and France. Konstantin Zhernosekov's co-authors include Roger Schibli, Cristina Müller, Α. Türler, Frank Rösch, D. V. Filosofov, Holger Dorrer, U. Köster, Richard P. Baum, H. Bihl and Markus Jahn and has published in prestigious journals such as Theranostics, Journal of Nuclear Medicine and Radiotherapy and Oncology.

In The Last Decade

Konstantin Zhernosekov

32 papers receiving 1.7k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Processing of Generator-Produced 68Ga for Medical Application

2007 419 citations Konstantin Zhernosekov, D. V. Filosofov et al. Journal of Nuclear Medicine profile →

Peers

Countries citing papers authored by Konstantin Zhernosekov

Since Specialization

Citations

This map shows the geographic impact of Konstantin Zhernosekov's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Konstantin Zhernosekov with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Konstantin Zhernosekov more than expected).

Fields of papers citing papers by Konstantin Zhernosekov

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Konstantin Zhernosekov. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Konstantin Zhernosekov. The network helps show where Konstantin Zhernosekov may publish in the future.

Co-authorship network of co-authors of Konstantin Zhernosekov

This figure shows the co-authorship network connecting the top 25 collaborators of Konstantin Zhernosekov. A scholar is included among the top collaborators of Konstantin Zhernosekov based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Konstantin Zhernosekov. Konstantin Zhernosekov is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Biodistribution and dosimetry of [177Lu]Lu-SibuDAB in patients with metastatic castration-resistant prostate cancer 2025 ·European Journal of Nuclear Medicine and Molecular Imaging ·Philipp Ritt, (unknown), Cristian Soza‐Ried, (unknown), Horacio Amaral, (unknown), Ana Katrina Mapanao, (unknown), Konstantin Zhernosekov, Roger Schibli, Cristina Müller, Vasko Kramer	3
2	Reduced Renal Uptake of Various Radiopharmaceuticals with Sodium Paraaminohippurate Coadministration in a Rat Model 2025 ·Journal of Nuclear Medicine ·Marian Meckel, (unknown), (unknown), Philipp Ritt, Margret I. Moré, Ralf Bergmann, Domokos Máthé, Konstantin Zhernosekov	0
3	The evolution of PRRT for the treatment of neuroendocrine tumors; What comes next? 2022 ·Frontiers in Endocrinology ·Philip E. Harris, Konstantin Zhernosekov	38
4	Development of a new class of PSMA radioligands comprising ibuprofen as an albumin-binding entity 2020 ·Theranostics ·(unknown), Martina Benešová, Christoph A. Umbricht, Francesca Borgna, (unknown), Konstantin Zhernosekov, Roger Schibli, Cristina Müller	72
5	Development of a [ ¹⁷⁷ Lu]BPAMD Labeling Kit and an Automated Synthesis Module for Routine Bone Targeted Endoradiotherapy 2015 ·Cancer Biotherapy and Radiopharmaceuticals ·Marian Meckel, Aaron Nauth, (unknown), Konstantin Zhernosekov, Ameya Puranik, Richard P. Baum, Frank Rösch	17
6	Radiosynthesis of clinical doses of 68 Ga-DOTATATE (GalioMedix™) and validation of organic-matrix-based 68 Ge/ 68 Ga generators 2015 ·Nuclear Medicine and Biology ·Izabela Tworowska, David Ranganathan, Sanjay Thamake, Ebrahim S. Delpassand, Alireza Mojtahedi, Michael K. Schultz, Konstantin Zhernosekov, Sebastian Marx	23
7	Anti-L1CAM radioimmunotherapy is more effective with the radiolanthanide terbium-161 compared to lutetium-177 in an ovarian cancer model 2014 ·European Journal of Nuclear Medicine and Molecular Imaging ·Jürgen Grünberg, (unknown), Holger Dorrer, Susan Cohrs, Konstantin Zhernosekov, U. Köster, Α. Türler, Eliane Fischer, Roger Schibli	59
8	Direct in vitro and in vivo comparison of 161Tb and 177Lu using a tumour-targeting folate conjugate 2013 ·European Journal of Nuclear Medicine and Molecular Imaging ·Cristina Müller, Josefine Reber, Stephanie Haller, Holger Dorrer, Peter Bernhardt, Konstantin Zhernosekov, Α. Türler, Roger Schibli	103
9	Promises of Cyclotron-Produced ⁴⁴Sc as a Diagnostic Match for Trivalent β⁻-Emitters: In Vitro and In Vivo Study of a ⁴⁴Sc-DOTA-Folate Conjugate 2013 ·Journal of Nuclear Medicine ·Cristina Müller, Maruta Bunka, Josefine Reber, Cindy R. Fischer, Konstantin Zhernosekov, Α. Türler, Roger Schibli	94
10	A Unique Matched Quadruplet of Terbium Radioisotopes for PET and SPECT and for α- and β⁻-Radionuclide Therapy: An In Vivo Proof-of-Concept Study with a New Receptor-Targeted Folate Derivative 2012 ·Journal of Nuclear Medicine ·Cristina Müller, Konstantin Zhernosekov, U. Köster, K. Johnston, Holger Dorrer, Alexander Höhn, (unknown), Α. Türler, Roger Schibli	189
11	DOTA Conjugate with an Albumin-Binding Entity Enables the First Folic Acid–Targeted ¹⁷⁷Lu-Radionuclide Tumor Therapy in Mice 2012 ·Journal of Nuclear Medicine ·Cristina Müller, Harriet Struthers, (unknown), Konstantin Zhernosekov, Roger Schibli	157
12	The Szilard–Chalmers effect in macrocyclic ligands to increase the specific activity of reactor-produced radiolanthanides: Experiments and explanations 2012 ·Radiochimica Acta ·Konstantin Zhernosekov, D. V. Filosofov, Frank Rösch	7
13	Development and evaluation of (44)Ti production on high energy protons 2011 ·Journal of Labelled Compounds and Radiopharmaceuticals ·Konstantin Zhernosekov, Maruta Bunka, Alexander Höhn, Roger Schibli, Α. Türler	1
14	Conceptual Design, Neutronic and Radioprotection Study of a Fast Neutron Irradiation Station at SINQ 2011 ·Bern Open Repository and Information System (University of Bern) ·L. Zanini, N. Baluc, Andrea De Simone, R. Eichler, (unknown), (unknown), M.A. Pouchon, (unknown), (unknown), (unknown), Konstantin Zhernosekov	1
15	The low-energy β− and electron emitter 161Tb as an alternative to 177Lu for targeted radionuclide therapy 2011 ·Nuclear Medicine and Biology ·(unknown), (unknown), Susan Cohrs, Eliane Fischer, Jürgen Grünberg, Alexander Höhn, U. Köster, Roger Schibli, Α. Türler, Konstantin Zhernosekov	128
16	Improved column-based radiochemical processing of the generator produced 68Ga 2011 ·Applied Radiation and Isotopes ·Natalia S. Loktionova, (unknown), D.V. Filosofov, Konstantin Zhernosekov, (unknown), Α. Türler, Frank Rösch	32
17	Target burn-up corrected specific activity of 177Lu produced via 176Lu(n, γ) 177Lu nuclear reactions 2008 ·Applied Radiation and Isotopes ·Konstantin Zhernosekov, R. C. Perego, (unknown), R. Henkelmann, Α. Türler	24
18	Processing of Generator-Produced 68Ga for Medical Application breakdown → 2007 ·Journal of Nuclear Medicine ·Konstantin Zhernosekov, D. V. Filosofov, Richard P. Baum, (unknown), H. Bihl, A. A. Razbash, Markus Jahn, M. Jennewein, Frank Rösch	419
19	Visualisation of a somatostatin receptor-expressing tumour with 67Ga-DOTATOC SPECT 2005 ·European Journal of Nuclear Medicine and Molecular Imaging ·Konstantin Zhernosekov, (unknown), (unknown), Markus Jahn, (unknown), (unknown), H. Bihl, Frank Rösch	9
20	Complex formation of Tb³⁺with glycolate,D-gluconate andα-isosaccharinate in neutral aqueous perchlorate solutions 2003 ·Radiochimica Acta ·Konstantin Zhernosekov, Eric Mauerhofer, (unknown), P. Warwick, Frank Rösch	6

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact